phosphorylcholine has been researched along with Stroke in 4 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to assess the diagnostic accuracy of autoantibodies to apolipoprotein A-1 (anti-apoA-1 IgG) and to phosphorylcholine (anti-PC IgM) for non-ST segment elevation acute myocardial infarction (NSTEMI) and to explore their potential prognostic value." | 7.81 | Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction. ( Grueter, D; Haaf, P; Jaeger, C; Montecucco, F; Mueller, C; Pagano, S; Reichlin, T; Rubini Gimenez, M; Twerenbold, R; Virzi, J; Vuilleumier, N; Wildi, K, 2015) |
| "Natural immunoglobulin M antibodies specific for phosphorylcholine (anti-PC) have been implicated in atherosclerosis." | 7.76 | Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. ( de Faire, U; Fiskesund, R; Frostegård, J; Hallmans, G; Stegmayr, B; Vikström, M; Weinehall, L, 2010) |
| "Natural antibodies specific for phosphorylcholine (anti-PC) have been implicated as protective factors in atherosclerosis." | 7.75 | Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. ( Berglund, G; Dahlbom, I; de Faire, U; Frostegård, J; Grönlund, H; Hedblad, B; Sjöberg, BG; Su, J; Wikström, M, 2009) |
| " We aimed to assess the diagnostic accuracy of autoantibodies to apolipoprotein A-1 (anti-apoA-1 IgG) and to phosphorylcholine (anti-PC IgM) for non-ST segment elevation acute myocardial infarction (NSTEMI) and to explore their potential prognostic value." | 3.81 | Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction. ( Grueter, D; Haaf, P; Jaeger, C; Montecucco, F; Mueller, C; Pagano, S; Reichlin, T; Rubini Gimenez, M; Twerenbold, R; Virzi, J; Vuilleumier, N; Wildi, K, 2015) |
| "Natural immunoglobulin M antibodies specific for phosphorylcholine (anti-PC) have been implicated in atherosclerosis." | 3.76 | Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. ( de Faire, U; Fiskesund, R; Frostegård, J; Hallmans, G; Stegmayr, B; Vikström, M; Weinehall, L, 2010) |
| "Natural antibodies specific for phosphorylcholine (anti-PC) have been implicated as protective factors in atherosclerosis." | 3.75 | Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. ( Berglund, G; Dahlbom, I; de Faire, U; Frostegård, J; Grönlund, H; Hedblad, B; Sjöberg, BG; Su, J; Wikström, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geller, BJ | 1 |
| Mega, JL | 1 |
| Morrow, DA | 1 |
| Guo, J | 1 |
| Hoffman, EB | 1 |
| Gibson, CM | 1 |
| Ruff, CT | 1 |
| Rubini Gimenez, M | 1 |
| Pagano, S | 1 |
| Virzi, J | 1 |
| Montecucco, F | 1 |
| Twerenbold, R | 1 |
| Reichlin, T | 1 |
| Wildi, K | 1 |
| Grueter, D | 1 |
| Jaeger, C | 1 |
| Haaf, P | 1 |
| Vuilleumier, N | 1 |
| Mueller, C | 1 |
| Sjöberg, BG | 1 |
| Su, J | 1 |
| Dahlbom, I | 1 |
| Grönlund, H | 1 |
| Wikström, M | 1 |
| Hedblad, B | 1 |
| Berglund, G | 1 |
| de Faire, U | 2 |
| Frostegård, J | 2 |
| Fiskesund, R | 1 |
| Stegmayr, B | 1 |
| Hallmans, G | 1 |
| Vikström, M | 1 |
| Weinehall, L | 1 |
1 trial available for phosphorylcholine and Stroke
| Article | Year |
|---|---|
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
Topics: Acute Coronary Syndrome; Aged; Antibodies, Antiphospholipid; Factor Xa Inhibitors; Female; Humans; I | 2014 |
3 other studies available for phosphorylcholine and Stroke
| Article | Year |
|---|---|
Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
Topics: Aged; Aged, 80 and over; Apolipoprotein A-I; Area Under Curve; Autoantibodies; Case-Control Studies; | 2015 |
Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.
Topics: Aged; Atherosclerosis; Brain Ischemia; Cardiovascular Diseases; Cholesterol; Cohort Studies; Female; | 2009 |
Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.
Topics: Adult; Aged; Antibodies; Atherosclerosis; Case-Control Studies; Female; Humans; Immunoglobulin M; Ma | 2010 |